Location History:
- Wako, JP (1980 - 1994)
- Kawagoe, JP (1993 - 1996)
Company Filing History:
Years Active: 1980-1996
Title: Masakatsu Ozeki: Innovator in Thiazine Derivatives
Introduction
Masakatsu Ozeki is a prominent inventor based in Wako, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of thiazine derivatives. With a total of 12 patents to his name, Ozeki's work has implications for the treatment of various neurological conditions.
Latest Patents
Ozeki's latest patents include innovative compounds that exhibit calcium antagonistic activity within cerebral tissues. One of his notable inventions is a thiazine derivative that has potential applications in the prophylaxis and treatment of ischemic encephalopathia. This compound features a complex formula where various substituents can be hydrogen, halogens, or other functional groups, allowing for a range of therapeutic applications. Another patent focuses on thiazine derivatives that can be utilized for treating cerebral neurocyte dyscrasia, showcasing his commitment to advancing medical science.
Career Highlights
Throughout his career, Masakatsu Ozeki has worked with reputable companies such as Tanabe Seiyaku Company, Limited and Tanabe Seikayu Co., Ltd. His experience in these organizations has allowed him to refine his expertise in pharmaceutical development and innovation. Ozeki's contributions have not only advanced his career but have also significantly impacted the field of medicinal chemistry.
Collaborations
Ozeki has collaborated with notable colleagues, including Ikuo Iijima and Kunihito Okumura. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pursuit of scientific advancement.
Conclusion
Masakatsu Ozeki is a distinguished inventor whose work in thiazine derivatives has the potential to transform treatments for neurological disorders. His extensive patent portfolio and collaborations highlight his dedication to innovation in the pharmaceutical industry.